The clinical and cost-effectiveness of radiofrequency ablation for lung cancer : in response to an enquiry from the National Cancer Waiting Times Delivery Group.
Healthcare Improvement Scotland.
Includes bibliographical references (pages 5-6).
System requirements: Adobe Reader required to view PDF document.
Description from online resource; title from PDF caption title (Healthcare Improvement Scotland, viewed 27 January 2021)
Lungs